Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01506934 · ClinicalTrials.gov registry record · Phase 1
A Study Evaluating the Bioavailability of Two Formulations of Linifanib and Food Effect on Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid Tumors
A Phase 1 study, sponsored by Abbott.
- Terminated
- Registry status
- Phase 1
- Development phase
- 14
- Enrollment target
NCT01506934 is a Phase 1 study that was terminated before completion, run by Abbott. The registered enrollment target is 14 participants.
The verdict
NCT01506934, a Phase 1 study, was terminated before completion, sponsored by Abbott.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 14 participants
- Enrollment target
Study Summary
A pharmacokinetic study to compare 2 clinical formulations of linifanib and the effect of food on the pharmacokinetics of linifanib.
Interventions
- DRUG linifanib
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2011-10 |
| Est. Completion | 2012-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01506934
The ClinicalTrials.gov registry entry for NCT01506934 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott, which has 181 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which linifanib is the first listed.
NCT01506934 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01506934 about?
NCT01506934 is a clinical study titled "A Study Evaluating the Bioavailability of Two Formulations of Linifanib and Food Effect on Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid Tumors". A pharmacokinetic study to compare 2 clinical formulations of linifanib and the effect of food on the pharmacokinetics of linifanib.
What is the current status of trial NCT01506934?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 14 participants. The study started on 2011-10. Estimated completion is 2012-01.
What interventions are being tested in trial NCT01506934?
The interventions under investigation include: linifanib (DRUG).
Who is sponsoring clinical trial NCT01506934?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.